IMCAS - Congresses on Dermatology and Aesthetic & Plastic Surgery

239 Updated and future aesthetic toxins

Saturday 03 February 2024

14:00 to 15:30

Amphi Havane - Level 3

FOCUS SESSION

Presidente (s) da sessão

Dr. Benjamin ASCHER

Cirurgião Plástico

França

Prof Mark Steven NESTOR

Dermatologista

Estados Unidos da América

Palestras da sessão

14:00

Introduction

14:03

PART 1 - 2024 update on novel toxins

14:03

Jon EDELSON

Update on Eirion’s topical and liquid injectable botulinum

14:12

Dr. Rui AVELAR

PrabotulinumtoxinA 40U long-duration formulation, phase II study final results - Evolus

14:21

Mickael MACHICOANE

Fast onset, long duration: “I want it all”? - Fastox

14:30

Xiaoming LIN

RelabotulinumtoxinA – Innovation From Lab to Clinic - Galderma

14:39

Dr. Conor GALLAGHER

DaxibotulinumtoxinA: an update from Revance

14:48

Panel discussion

14:58

PART 2 - New toxins from Asia

14:58

Dr. Choon Shik YOON

The pioneer and innovator: Asia's first FDA-approved Botulinum Toxin, Prabotulinumtoxin A - New indication introduction - Daewoong

15:08

Dr. Hyoung Jin MOON

New clinical evidence of LetibotulinumtoxinA: beyond Asia to the world - Hugel

15:18

Panel discussion & closing

15:28

Conclusion

Sessões recomendadas

Indústria Simpósio

VIVACY Symposium with live demo - V for Virtual by VIVACY: Exploring New Possibilities in Aesthetic Practice 178, 179

Medical rhinoplasty 199

Indústria Simpósio

FIDIA Symposium - An Innovative Path to Natural Beauty: Beyond Biostimulation with Auto-Crosslinked HA Technology 244

Indústria Simpósio

MERZ AESTHETICS Symposium - Mastering regenerative biostimulation 116, 117

Ultrasonography (in collaboration with CUTANEOUS) 131, 132

Tem uma pergunta?

Aviso

Presidente (s) da sessão

Palestras da sessão

Sessões recomendadas

Tem uma pergunta?

Erro